• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.41% Nasdaq Up 0.22%

    Ariad Pharmaceuticals Inc. (ARIA)

    -NasdaqGS
    7.18 Down 0.04(0.60%) 10:11AM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:7.22
    Open:7.30
    Bid:7.25 x 26800
    Ask:7.26 x 1400
    1y Target Est:8.16
    Beta:0.86
    Earnings Date:Feb 23 - Feb 27 (Est.)
    Day's Range:7.01 - 7.33
    52wk Range:4.90 - 9.83
    Volume:1,126,494
    Avg Vol (3m):6,901,270
    Market Cap:1.34B
    P/E (ttm):N/A
    EPS (ttm):-1.24
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ARIA

    Comparison

    Symbol% ChgMkt Cap
    ARIADown 0.60%1.34B
    NVSUp 0.66%230.33B
    PFEUp 0.13%201.50B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):28.80
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-1.10
    Quarterly EPS Est (Dec-14) :-0.27
    Mean Recommendation*:2.6
    PEG Ratio (5 yr expected):-0.16

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    ARIAD Pharmaceuticals, Inc., an oncology company, is engaged in the discovery, development, and commercialization of medicines for cancer patients. It offers Iclusig (ponatinib), a tyrosine kinase inhibitor for the treatment of adult patients with... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback